Ian R. Logan

1.3k total citations
16 papers, 1.0k citations indexed

About

Ian R. Logan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Ian R. Logan has authored 16 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Genetics. Recurrent topics in Ian R. Logan's work include Ubiquitin and proteasome pathways (6 papers), Prostate Cancer Treatment and Research (5 papers) and Genomics and Chromatin Dynamics (3 papers). Ian R. Logan is often cited by papers focused on Ubiquitin and proteasome pathways (6 papers), Prostate Cancer Treatment and Research (5 papers) and Genomics and Chromatin Dynamics (3 papers). Ian R. Logan collaborates with scholars based in United Kingdom, Australia and France. Ian R. Logan's co-authors include Craig Robson, Vasileia Sapountzi, Luke Gaughan, Susan Cook, David E. Neal, Hing Y. Leung, Vincent J. Gnanapragasam, Mark E. Brady, Stuart McCracken and John Lunec and has published in prestigious journals such as The Lancet, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Ian R. Logan

15 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ian R. Logan United Kingdom	11	823	283	228	170	91	16	1.0k
Kevin M. Regan United States	16	1.1k 1.3×	240 0.8×	341 1.5×	220 1.3×	230 2.5×	19	1.3k
Susan Ha United States	16	494 0.6×	104 0.4×	235 1.0×	186 1.1×	105 1.2×	26	701
Ding-Yen Lin Taiwan	11	702 0.9×	170 0.6×	60 0.3×	138 0.8×	115 1.3×	15	854
Hyang‐Sook Yoo South Korea	22	898 1.1×	151 0.5×	97 0.4×	141 0.8×	275 3.0×	43	1.1k
Lowell G. Sheflin United States	16	687 0.8×	86 0.3×	76 0.3×	126 0.7×	94 1.0×	34	875
Karen W. Barbour United States	16	426 0.5×	209 0.7×	58 0.3×	61 0.4×	86 0.9×	30	721
J. Suso Platero United States	11	987 1.2×	75 0.3×	108 0.5×	172 1.0×	97 1.1×	12	1.2k
Alexandra Debernardi France	8	950 1.2×	188 0.7×	175 0.8×	79 0.5×	206 2.3×	8	1.1k
Marta Taulés Spain	9	458 0.6×	91 0.3×	76 0.3×	90 0.5×	101 1.1×	13	636
Yu‐Chi Juang United States	14	801 1.0×	176 0.6×	53 0.2×	58 0.3×	105 1.2×	16	922

Countries citing papers authored by Ian R. Logan

Since Specialization

Citations

This map shows the geographic impact of Ian R. Logan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian R. Logan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian R. Logan more than expected).

Fields of papers citing papers by Ian R. Logan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian R. Logan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian R. Logan. The network helps show where Ian R. Logan may publish in the future.

Co-authorship network of co-authors of Ian R. Logan

This figure shows the co-authorship network connecting the top 25 collaborators of Ian R. Logan. A scholar is included among the top collaborators of Ian R. Logan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian R. Logan. Ian R. Logan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Thompson, Philip E., Ian R. Logan, Charles Tomson, Neil Sheerin, & Timothy Ellam. (2020). Obesity, Sex, Race, and Early Onset Hypertension. Hypertension. 76(3). 859–865. 16 indexed citations

Odudu, Aghogho, et al.. (2019). Changing Protein Permeability with Nephron Loss: Evidence for a Human Remnant Nephron Effect. American Journal of Nephrology. 50(2). 152–159. 2 indexed citations

Gaughan, Luke, et al.. (2017). The methyltransferase SET9 regulates TGFB1 activation of renal fibroblasts via interaction with SMAD3. Journal of Cell Science. 131(1). 20 indexed citations

Logan, Ian R., et al.. (2017). Severe acute kidney injury associated with immersion into seawater. Cogent Medicine. 4(1). 1297190–1297190.

Logan, Ian R., et al.. (2016). Epigenetic regulators, including SETD7, as new targets for the treatment of chronic kidney disease. The Lancet. 387. S66–S66. 1 indexed citations

Logan, Ian R., Urszula L. McClurg, Dominic Jones, et al.. (2016). Nutlin-3 inhibits androgen receptor-driven c-FLIP expression, resulting in apoptosis of prostate cancer cells. Oncotarget. 7(46). 74724–74733. 5 indexed citations

Harle, Victoria, Kelly Coffey, Steven Darby, et al.. (2013). Deubiquitinating Enzyme Usp12 Is a Novel Co-activator of the Androgen Receptor. Journal of Biological Chemistry. 288(45). 32641–32650. 80 indexed citations

Logan, Ian R., Hesta McNeill, Susan Cook, et al.. (2009). Heat shock factor-1 modulates p53 activity in the transcriptional response to DNA damage. Nucleic Acids Research. 37(9). 2962–2973. 49 indexed citations

Sapountzi, Vasileia, Ian R. Logan, Glyn Nelson, Susan Cook, & Craig Robson. (2007). Phosphorylation of Tat-interactive protein 60 kDa by protein kinase Cε is important for its subcellular localisation. The International Journal of Biochemistry & Cell Biology. 40(2). 236–244. 3 indexed citations

10.

Logan, Ian R., Hesta McNeill, Susan Cook, et al.. (2007). Analysis of the MDM2 antagonist nutlin‐3 in human prostate cancer cells. The Prostate. 67(8). 900–906. 37 indexed citations

11.

Sapountzi, Vasileia, Ian R. Logan, & Craig Robson. (2006). Cellular functions of TIP60. The International Journal of Biochemistry & Cell Biology. 38(9). 1496–1509. 215 indexed citations

12.

Logan, Ian R., Luke Gaughan, Stuart McCracken, et al.. (2006). Human PIRH2 Enhances Androgen Receptor Signaling through Inhibition of Histone Deacetylase 1 and Is Overexpressed in Prostate Cancer. Molecular and Cellular Biology. 26(17). 6502–6510. 77 indexed citations

13.

Chen, Mingzhou, Jc Cortay, Ian R. Logan, et al.. (2005). Inhibition of Ubiquitination and Stabilization of Human Ubiquitin E3 Ligase PIRH2 by Measles Virus Phosphoprotein. Journal of Virology. 79(18). 11824–11836. 43 indexed citations

14.

Logan, Ian R., Vasileia Sapountzi, Luke Gaughan, David E. Neal, & Craig Robson. (2004). Control of Human PIRH2 Protein Stability. Journal of Biological Chemistry. 279(12). 11696–11704. 58 indexed citations

15.

Gnanapragasam, Vincent J., Ian R. Logan, Mark E. Brady, et al.. (2003). Expression of Tip60, an androgen receptor coactivator, and its role in prostate cancer development. Oncogene. 22(16). 2466–2477. 171 indexed citations

16.

Gaughan, Luke, Ian R. Logan, Susan Cook, David E. Neal, & Craig Robson. (2002). Tip60 and Histone Deacetylase 1 Regulate Androgen Receptor Activity through Changes to the Acetylation Status of the Receptor. Journal of Biological Chemistry. 277(29). 25904–25913. 246 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact